BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 12187093)

  • 1. Renal transplantation of highly sensitised patients via prioritised renal allocation programs. Shorter waiting time and above-average graft survival.
    De Meester J; Doxiadis II; Persijn GG; Claas FH
    Nephron; 2002 Sep; 92(1):111-9. PubMed ID: 12187093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
    Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
    Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey.
    Assfalg V; Hüser N; van Meel M; Haller B; Rahmel A; de Boer J; Matevossian E; Novotny A; Knops N; Weekers L; Friess H; Pratschke J; Függer R; Janko O; Rasoul-Rockenschaub S; Bosmans JL; Broeders N; Peeters P; Mourad M; Kuypers D; Slaviček J; Muehlfeld A; Sommer F; Viebahn R; Pascher A; van der Giet M; Zantvoort F; Woitas RP; Putz J; Grabitz K; Kribben A; Hauser I; Pisarski P; Weimer R; Lorf T; Fornara P; Morath C; Nashan B; Lehner F; Kliem V; Sester U; Grimm MO; Feldkamp T; Kleinert R; Arns W; Mönch C; Schoenberg MB; Nitschke M; Krüger B; Thorban S; Arbogast HP; Wolters HH; Maier T; Lutz J; Heller K; Banas B; Hakenberg O; Kalus M; Nadalin S; Keller F; Lopau K; Bemelman FJ; Nurmohamed S; Sanders JS; de Fijter JW; Christiaans M; Hilbrands L; Betjes M; van Zuilen A; Heemann U
    Nephrol Dial Transplant; 2016 Sep; 31(9):1515-22. PubMed ID: 26908765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An algorithm for cadaver kidney allocation based on a multivariate analysis of factors impacting on cadaver kidney graft survival and function.
    Poli F; Scalamogna M; Cardillo M; Porta E; Sirchia G
    Transpl Int; 2000; 13 Suppl 1():S259-62. PubMed ID: 11112008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new Eurotransplant Kidney Allocation System: report one year after implementation. Eurotransplant International Foundation.
    De Meester J; Persijn GG; Wujciak T; Opelz G; Vanrenterghem Y
    Transplantation; 1998 Nov; 66(9):1154-9. PubMed ID: 9825810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme.
    Bentas W; Jones J; Karaoguz A; Tilp U; Probst M; Scheuermann E; Hauser IA; Jonas D; Gossmann J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2043-51. PubMed ID: 18203840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
    Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
    Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for compensating for the declining numbers of cadaver donor kidney transplants.
    Palmes D; Wolters HH; Brockmann J; Senninger N; Spiegel HU; Dietl KH
    Nephrol Dial Transplant; 2004 Apr; 19(4):952-62. PubMed ID: 15031355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Eurotransplant kidney allocation simulations demonstrate the feasibility and benefit of T-cell epitope matching.
    Niemann M; Lachmann N; Geneugelijk K; Spierings E
    PLoS Comput Biol; 2021 Jul; 17(7):e1009248. PubMed ID: 34314431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplanting the elderly: Balancing aging with histocompatibility.
    Dreyer GJ; Hemke AC; Reinders ME; de Fijter JW
    Transplant Rev (Orlando); 2015 Oct; 29(4):205-11. PubMed ID: 26411382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs.
    Roodnat JI; van de Wetering J; Claas FH; Ijzermans J; Weimar W
    Transpl Int; 2012 Sep; 25(9):987-93. PubMed ID: 22775425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.
    Mumford L; Fuggle SV; Martorell J; Slavcev A; Iniotaki A; Haasnoot GW; Heidt S; Claas FHJ
    Transpl Immunol; 2021 Feb; 64():101354. PubMed ID: 33276060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups.
    Roberts JP; Wolfe RA; Bragg-Gresham JL; Rush SH; Wynn JJ; Distant DA; Ashby VB; Held PJ; Port FK
    N Engl J Med; 2004 Feb; 350(6):545-51. PubMed ID: 14762181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program.
    Frei U; Noeldeke J; Machold-Fabrizii V; Arbogast H; Margreiter R; Fricke L; Voiculescu A; Kliem V; Ebel H; Albert U; Lopau K; Schnuelle P; Nonnast-Daniel B; Pietruck F; Offermann R; Persijn G; Bernasconi C
    Am J Transplant; 2008 Jan; 8(1):50-7. PubMed ID: 17973969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.